Report Highlights
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
Report Includes
- 57 data tables and 43 additional tables
- In-depth analysis of the global markets for chronic kidney diseases (CKD) and related technologies
- Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the current market size and revenue forecasts, along with a corresponding market share analysis by product type, application, end-user and region
- Facts and figures pertaining to the market dynamics, technological advances, regulations, prospects, reimbursement practices, and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Information on current state of chronic kidney disease, with an emphasis on biomarkers, diagnostic methods and mobile apps that support effective disease state management
- Key insight into research on CKD comorbidities such as diabetes and metabolic disease, as well as treatment methods and diagnostics
- Review of key granted and published patents
- Analysis of the industry structure, including companies’ shares and global rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Company profiles of major players within the industry, including Fresenius Medical Care AG, Baxter, B. Braun SE, NIPRO, and Medtronic
Report Scope
The global market for chronic kidney disease is segmented by technology type, pharmaceutical drugs, and end users. From a technological perspective, the market is divided into diagnostic, therapeutic, and renal replacement solutions. Diagnostic technologies encompass biomarker-driven assays, imaging techniques, point-of-care testing, and genomic and proteomic screening, which facilitate early diagnosis and ongoing disease assessment. Therapeutic technologies encompass conventional drug treatments, innovative cell- and gene-based therapies, and advanced drug delivery systems, designed to slow disease progression and enhance patient outcomes. Renal replacement technologies, such as hemodialysis, peritoneal dialysis, and bioengineered artificial kidneys, are predominantly utilized in late-stage and end-stage CKD management.
In terms of pharmaceutical drugs, the market is segmented by CKD stage (Stage 1-5) and by medications used for dialysis and post-transplant care. This segmentation reflects the varying therapeutic requirements associated with disease severity and treatment settings. Based on end users, the market is classified into hospitals, clinics, and home-based or in-house dialysis settings. Hospitals and clinics account for the largest share due to comprehensive care capabilities, but the home care segment is experiencing rapid growth driven by increased patient preference, convenience, and advances in dialysis technologies. For market estimates, data has been provided for 2024 as the base year, 2025 as the estimated year, and with forecasts for 2026 through 2030.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $48.5 billion | ||||||||||||||||
| Market size forecast | $82.6 billion | ||||||||||||||||
| Growth rate | CAGR of 9.3% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Technology, Pharmaceutical Drugs, End User | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, Italy, Spain, U.K., Switzerland, Denmark, Belgium, the Netherlands, Sweden, Russia, China, India, Japan, Australia, South Korea, New Zealand, Singapore, Malaysia, Thailand, Indonesia, Brazil, Argentina, Colombia, Paraguay, Peru, Chile, Venezuela | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- High Progression rate for early-stage to end-stage renal diseases (ESRD)
- Increased number of dialysis centers and laboratories
- Shifting to home-based and digital renal care as a prevention
- Key restraints include - Low awareness and late diagnosis, High capital and high cost of treatment and limited reimbursement, Stringent regulatory and approval requirements
- Key opportunities include - Growing investments in regenerative medicine and biologics therapies, Expanding research and development efforts by industry leaders, Research and development initiatives from key companies
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
AI in Biotechnology: Global Markets
The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
AI in Healthcare Regional Analysis Market: Middle East and North Africa
This report provides an analysis of artificial intelligence (AI) in healthcare markets in the Middle East and North Africa (MENA) region. It covers various aspects of the market, including technological advances, economic factors, and business considerations, and provides insights into the different segments. The report delves into the key players engaged in healthcare AI industry.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Chronic Kidney Disease: Global Markets and Technologies
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
State of the Life Sciences Industry - 2026 First Quarter Review
Explore BCC Research’s Q1 2026 review of the life sciences industry, covering market trends, innovation, sector performance, and growth outlook.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Technologies for Long-Term Care and Home Healthcare: Global Markets
The global market for technologies for long-term care and home healthcare is estimated to grow from $46.2 billion in 2025 to $64.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7% from 2025 to 2030.
Top Trending Reports
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
2025 Semiconductor Manufacturing Research Review
Explore BCC Research’s 2025 Semiconductor Manufacturing Research Review covering key market trends, technology advances, materials, packaging, wafers and growth opportunities across the industry.
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Report Highlights
The global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate (CAGR) of 3.8% for the period of 2018-2023.
Report Includes
- 37 data tables and 22 additional tables
- A detailed overview of the global markets for Chronic Kidney Disease (CKD)
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Information on current state of chronic kidney disease, with an emphasis on biomarkers, diagnostic methods, and mobile apps that support effective disease state management
- Key insight into research on CKD comorbidities such as Diabetes and Metabolic Disease, as well as treatment methods and diagnostics
- A look at the impact of regulatory, environmental, and legislative issues on the global CKD market
- Profiles of major market players within the industry, including Abbott Laboratories, Eli Lilly and Co., Eisai, Inc., Merck & Co. and Sanofi-Aventis
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More